RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Aug 13, 2021

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

Jul 30, 2021

View Twitter Thread To watch me deliver the full lecture and view the presentation, click here. I recently gave a lecture about COVID-19 and vaccination with specific information for patients with IBD. This lecture was recorded on July 21st, before the CDC issued...

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study

Apr 18, 2021

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study David T. Rubin View Twitter Thread I've previously commented about the CLARITY IBD Study (Kennedy, et al). paper in this forum, but it bears repeating and further...

SARS Vaccine and IBD Tweetorial Summary from December 1

Dec 5, 2020

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Approach to Management and Interpretation of Testing Results in Patients with IBD, with Particular Attention to Restarting Therapy

Apr 21, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine As testing for SARS-CoV-2 is expanded and serologic antibody testing becomes available, we are faced with a number of different clinical scenarios. I have outlined the different situations...

Three waves of Illness from the COVID-19 Pandemic

Apr 1, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

Dr. David T. Rubin Shares Expert Advice on How to Get Your Work Published

by David Rubin | January 28, 2022 | In the Press | 0 Comments

Originally presented at the Crohn’s and Colitis Congress with colleagues Fabio Cominelli, MD, PhD, of Case Western Reserve University, and Siddharth Singh, MD, of the University of California San Diego, Rubin highlighted the importance of choosing the most appropriate...

Newly Discovered Vascular Barrier in the Brain May Explain IBD-Related Anxiety, Depression

by nmgarcia | November 9, 2021 | In the Press | 0 Comments

A newly discovered vascular brain barrier that blocks the passage of inflammatory molecules triggered by gut bacteria may be why patients with inflammatory bowel disease (IBD) are at increased risk for certain mental health disorders, including anxiety and depression,...

Definition of “healing” and sustained remission

by dtrubin | December 6, 2019 | histology, normalization, Rubin's Reflections | 0 Comments

The FDA and others have been interested in the role of histology for assessing “deeper” levels of disease control, with the premise that biopsy may reflect the state of the disease more accurately and perhaps more objectively than endoscopy, and certainly more than...

Dr. David T. Rubin Hosts Pearls from the Pros on IBD Management

by David Rubin | March 1, 2022 | In the Press | 0 Comments

Dr. Rubin hosted four episodes of MedEd Talks Gastroenterology's Pearls from the Pros on IBD Management, featuring several colleagues to discuss best practices in using different classes of IBD therapies. Dr. Rubin spoke with Dr. Bruce Sands, Gastroenterologist and...

Three waves of Illness from the COVID-19 Pandemic

by dtrubin | April 1, 2020 | Coronavirus, Rubin's Reflections | 0 Comments

Dr. David T. Rubin Summarizes His Presentation from the Advances in Inflammatory Bowel Diseases Conference on Preparing for IBD Care in the Next Pandemic

by nmgarcia | December 13, 2021 | In the Press | 0 Comments

Click here for the full video of Dr. Rubin detailing his 8-point strategy for steps the gastroenterology community should take to prepare for another pandemic in the future to ensure the best outcomes for patients and conditions for professionals.

Dr. David T. Rubin and His Colleagues Discuss COVID-19 Vaccines for Patients with IBD

by David Rubin | May 4, 2021 | In the Press | 0 Comments

Click here for the full video of Drs. Rubin, Siegel, Melmed, and Horrigan discussing the safety and efficacy of COVID-19 vaccines for patients with inflammatory bowel disease.

G&E News Expert Picks by Dr. Rubin: Best of ECCO 2019

by dtrubin | September 18, 2019 | In the Press | 0 Comments

'In this installment of “Expert Picks,” David Rubin, MD, the Joseph B. Kirsner Professor of Medicine; the chief of the Section of Gastroenterology, Hepatology, and Nutrition; and a co-director of the Digestive Diseases Center at the University of Chicago Medicine and...

Hospital-stay duration after IBD surgery not linked to sleep, activity

by dtrubin | December 16, 2019 | biosensor, In the Press | 0 Comments

Second-year Pritzker medical student, Yangtian Yi, received Best Abstract in Surgery at AIBD 2019 for his abstract associating length of stay for IBD surgical patients with data collected from wearable devices. His oral presentation and abstract was reported on by...

How IBD Can Affect Patients’ Career and School Choices

by dtrubin | December 3, 2019 | QoL, Rubin's Reflections | 0 Comments

IBD, perhaps more than other chronic illnesses, can have a definite impact on a patient’s career choices and school performance. Therefore, I have definitely seen patients make decisions that are affected by their IBD. However, more often, I’ve seen patients overcome...